Our epidemiological analyses are based upon the most relevant and representative studies. Methodology is clear, quantifiable, and drawn up on oncology databases, and cancer journals. We cover the seven major mature markets (the US, Japan, France, Germany, Italy, Spain, and the UK) as well as key emerging countries for this left side list of cancers.

25 items